Mira Pharmaceuticals (MIRA) Operating Expenses (2022 - 2025)

Mira Pharmaceuticals has disclosed Operating Expenses across 4 years of filings, most recently posting $5.8 million for Q4 2025.

• Operating Expenses for Q4 2025 came in at $5.8 million, up 138.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.5 million (up 30.86% YoY), and the FY2025 annual result was $10.5 million, up 30.86% from the prior year.
• Operating Expenses came in at $5.8 million for Q4 2025 at Mira Pharmaceuticals, up from $1.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $5.8 million in Q4 2025 to a low of $970220.0 in Q2 2023.
• The 4-year median for Operating Expenses is $1.8 million (2025), against an average of $2.2 million.
• Across the five-year window, Operating Expenses tumbled 59.92% in 2023 and surged 138.94% in 2025, its largest moves.
• Mira Pharmaceuticals' Operating Expenses stood at $1.3 million in 2022, then surged by 126.78% to $3.1 million in 2023, then retreated by 20.24% to $2.4 million in 2024, then jumped by 138.94% to $5.8 million in 2025.
• The last three Operating Expenses figures came in at $5.8 million (Q4 2025), $1.3 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.